Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)

NARecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
QutenzaDuloxetineChemotherapy-induced Peripheral NeuropathyCIPN - Chemotherapy-Induced Peripheral Neuropathy
Interventions
DRUG

Qutenza

Capsaicine patch: Qutenza 8% patch will be applied to the skin according to the instruction of the manufacturer. After application of local anesthetics on the skin, a Qutenza 8% patch will be placed. 1-4 patches will be placed and can be adjusted to the right size, depending on the surface of the CIPN. The patch(es) will be removed after 30-60 minutes. The effect will last about 12 weeks.

DRUG

Duloxetine

Duloxetine tablets: In week 1 patients will receive 30 mg duloxetine one time per day. In week 2 the dose will be increased to 60 mg one time per day. In case of inacceptable adverse events the patient is allowed to reduce the dose to 30 mg one time per day after consultation with the researcher or physician.

Trial Locations (1)

Unknown

RECRUITING

Amsterdam UMC, locatie VUMC, Amsterdam

All Listed Sponsors
collaborator

Leiden University Medical Center

OTHER

collaborator

Reinier de Graaf Groep

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER